These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31776649)

  • 41. Acute neurological symptoms secondary to hypomagnesemia induced by proton pump inhibitors: a case series.
    Pasina L; Zanotta D; Puricelli S; Bonoldi G
    Eur J Clin Pharmacol; 2016 May; 72(5):641-3. PubMed ID: 26874835
    [No Abstract]   [Full Text] [Related]  

  • 42. Clinical predictors associated with proton pump inhibitor-induced hypomagnesemia.
    Kim S; Lee H; Park CH; Shim CN; Lee HJ; Park JC; Shin SK; Lee SK; Lee YC; Kim HY; Kang DR
    Am J Ther; 2015; 22(1):14-21. PubMed ID: 23846522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series.
    Mackay JD; Bladon PT
    QJM; 2010 Jun; 103(6):387-95. PubMed ID: 20378675
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypomagnesaemia and hypocalcaemia in a patient with systemic sclerosis: role of proton pump inhibitors.
    Perez MO; Neves EF; Bortolai CB; Sampaio-Barros PD; Andrade DC; Seguro LP
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-225-7. PubMed ID: 25068521
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Uses of proton pump inhibitors and hypomagnesemia.
    Gau JT; Yang YX; Chen R; Kao TC
    Pharmacoepidemiol Drug Saf; 2012 May; 21(5):553-9. PubMed ID: 22337212
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inulin significantly improves serum magnesium levels in proton pump inhibitor-induced hypomagnesaemia.
    Hess MW; de Baaij JH; Broekman M; Bisseling TM; Haarhuis B; Tan A; Te Morsche R; Hoenderop JG; Bindels RJ; Drenth JP
    Aliment Pharmacol Ther; 2016 Jun; 43(11):1178-85. PubMed ID: 27086738
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Automatic laboratory interventions to unmask and treat hypomagnesemia in the Emergency Department.
    Salinas M; Flores E; López-Garrigós M; Puche C; Leiva-Salinas C
    Clin Biochem; 2020 Jan; 75():48-52. PubMed ID: 31786206
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of proton pump inhibitors on Magnesium levels in Type II diabetic patients: a single centre study from Saudi Arabia.
    Lateef Junaid MA; Faraz A; Vaseem M; Salih IMA; Kutbi HAH; Al Julifi MZ; Alfhaid FM; Sami W
    Eur Rev Med Pharmacol Sci; 2023 Feb; 27(3):1077-1082. PubMed ID: 36808355
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extreme hypomagnesemia: characteristics of 119 consecutive inpatients.
    Cheminet G; Clain G; Jannot AS; Ranque B; Passeron A; Michon A; De Luna G; Diehl JL; Oudard S; Cellier C; Karras A; Vedié B; Prot-Bertoye C; Pouchot J; Arlet JB
    Intern Emerg Med; 2018 Dec; 13(8):1201-1209. PubMed ID: 29951810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypomagnesemic hypokalemia and hypocalcemia: clinical and laboratory characteristics.
    Elisaf M; Milionis H; Siamopoulos KC
    Miner Electrolyte Metab; 1997; 23(2):105-12. PubMed ID: 9252977
    [TBL] [Abstract][Full Text] [Related]  

  • 51. May hypomagnesaemia; caused by proton pump inhibitor; increase atrial fibrillation risk?
    Aparci M; Uz Ö; Atalay M; Uzun M
    Int J Cardiol; 2016 Mar; 207():141. PubMed ID: 26802817
    [No Abstract]   [Full Text] [Related]  

  • 52. Hypomagnesemia and proton-pump inhibitors.
    Famularo G; Gasbarrone L; Minisola G
    Expert Opin Drug Saf; 2013 Sep; 12(5):709-16. PubMed ID: 23808631
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Severe Electrolyte Disturbances Due to Proton Pump Inhibitor Therapy: An Underrecognized Problem with Potentially Severe Sequelae.
    Tagboto S
    Am J Case Rep; 2022 Jul; 23():e936893. PubMed ID: 35836357
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Hypomagnesemia and proton pump inhibitors].
    Fumeaux C; Schmidtko J; Meier P
    Rev Med Suisse; 2012 Apr; 8(336):806-10. PubMed ID: 22574415
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proton pump inhibitors and risk of hypomagnesemia.
    Pasina L; Zanotta D; Puricelli S; Djignefa DC; Bonoldi G
    Eur J Intern Med; 2015 Sep; 26(7):e25-6. PubMed ID: 26165831
    [No Abstract]   [Full Text] [Related]  

  • 56. An Interesting Case of "Refractory" Hypomagnesemia.
    Koh ZY; Lim SWM; Lim WS
    J Am Med Dir Assoc; 2017 Jul; 18(7):632-633. PubMed ID: 28549719
    [No Abstract]   [Full Text] [Related]  

  • 57. Lansoprazole-induced hypomagnesaemia.
    Krupa LZ; Fellows IW
    BMJ Case Rep; 2014 Jan; 2014():. PubMed ID: 24414180
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanisms and causes of hypomagnesemia.
    Agus ZS
    Curr Opin Nephrol Hypertens; 2016 Jul; 25(4):301-7. PubMed ID: 27219040
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Severe hypomagnesaemia in long-term users of proton-pump inhibitors.
    Cundy T; Dissanayake A
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):338-41. PubMed ID: 18221401
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Severe symptomatic hypomagnesaemia induced by the chronic use of proton pump inhibitors: a case report of a patient with Zollinger-Ellison syndrome.
    Ströker E; Leone L; Vandeput Y; Borbath I; Lefebvre C
    Acta Clin Belg; 2014; 69(1):62-5. PubMed ID: 24635401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.